TerminatedNot Applicable

Medical Assistance for the Procreation and Risk of Thrombosis.

Stopped: RECRUITMENT DIFFICULTIES

France129 participantsStarted 2016-02-02

Plain-language summary

This study aims at evaluating clincal practice regarding prevention of arterial and venous thrombosis following ovarian stimulation. Secondary outcomes are : 1) to describe the incidence and risk factors of arterial and venous thrombosis in women undergoing assisted reproductive technology and 2)to identify the incidence and risk factors for ovarian hyperstimulation syndrome in these women

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All women undergoing ovarian stimulation in order to receive in vitro fertilization Exclusion Criteria: * Age\<18 years * Women refusing to particpate in the study * No health coverage * Women under guardianship * Women receiving therapeutic doses of anticoagulation

What they're measuring

Evaluation of professional clinical practice for ovarian stimulation care

Timeframe: Until 12 months followin ovarian stimulation

Trial details

NCT IDNCT02610608

SponsorUniversity Hospital, Brest

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2016-11-20

View on ClinicalTrials.gov More Ovarian Hyperstimulation Syndrome trials